Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals has disclosed FCF Payout Ratio across 5 years of filings, most recently posting 0.01 for Q3 2025.

• FCF Payout Ratio for Q3 2025 came in at 0.01, down 44.31% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0 (down 84.71% YoY), and the FY2025 annual result was 0.01, down 80.15% from the prior year.
• FCF Payout Ratio came in at 0.01 for Q3 2025 at Ani Pharmaceuticals, up from 0.01 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.57 in Q4 2024 to a low of 0.05 in Q4 2022.
• The 5-year median for FCF Payout Ratio is 0.01 (2023), against an average of 0.12.
• Across the five-year window, FCF Payout Ratio slumped 249.79% in 2022 and soared 17142.86% in 2024, its largest moves.
• Ani Pharmaceuticals' FCF Payout Ratio stood at 0.02 in 2021, then tumbled by 249.79% to 0.05 in 2022, then soared by 116.84% to 0.01 in 2023, then jumped by 17142.86% to 1.57 in 2024, then slumped by 99.31% to 0.01 in 2025.
• The last three FCF Payout Ratio figures came in at 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025), per Business Quant data.